{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:21:09Z","timestamp":1790000469550,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000866","name":"International AIDS Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.01.040","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T01:39:33Z","timestamp":1454377173000},"page":"1405-1411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of the non-toxic mutant of the diphtheria toxin K51E\/E148K as carrier protein for meningococcal vaccines"],"prefix":"10.1016","volume":"34","author":[{"given":"S.","family":"Pecetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vijayakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Lo","family":"Surdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Balocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.G.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.vaccine.2016.01.040_bib0200","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.040_bib0205","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0041-0101(01)00165-9","article-title":"Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century","volume":"39","author":"Collier","year":"2001","journal-title":"Toxicon"},{"issue":"12","key":"10.1016\/j.vaccine.2016.01.040_bib0210","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1016\/S0021-9258(18)93347-8","article-title":"Diphtheria toxin-dependent adenosine diphosphate ribosylation of aminoacyl transferase II and inhibition of protein synthesis","volume":"243","author":"Honjo","year":"1968","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.040_bib0215","first-page":"524","article-title":"Diphtheria toxoid as an immunizing agent","volume":"17","author":"Fitzgerald","year":"1927","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2016.01.040_bib0220","first-page":"9","article-title":"Diphtheria vaccine","volume":"81","author":"Organization","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"issue":"35","key":"10.1016\/j.vaccine.2016.01.040_bib0225","first-page":"8","article-title":"Mutation in the structural gene for diphtheria toxin carried by temperate phage","volume":"233","author":"Uchida","year":"1971","journal-title":"Nat: New Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.040_bib0230","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.040_bib0235","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/S0021-9258(19)43810-6","article-title":"Diphtheria toxin and related proteins, I. Isolation and properties of mutant proteins serologically related to diphtheria toxin","volume":"248","author":"Uchida","year":"1973","journal-title":"J Biol Chem"},{"issue":"27","key":"10.1016\/j.vaccine.2016.01.040_bib0240","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.040_bib0245","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1469-0691.2003.00530.x","article-title":"Carbohydrate-protein conjugate vaccines","volume":"9","author":"Ada","year":"2003","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.040_bib0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.01.040_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07388551.2015.1084264","article-title":"Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications","volume":"18","author":"Gupta","year":"2015","journal-title":"Crit Rev Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.040_bib0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pep.2011.09.010","article-title":"Reliable protein production in a Pseudomonas fluorescens expression system","volume":"81","author":"Retallack","year":"2012","journal-title":"Protein Expr Purif"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.040_bib0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Broker","year":"2011","journal-title":"Biologicals"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.01.040_bib0270","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0264-410X(01)00364-4","article-title":"Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen","volume":"20","author":"Paoletti","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.040_bib0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jb\/mvm115","article-title":"Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin","volume":"142","author":"Kimura","year":"2007","journal-title":"J Biochem"},{"key":"10.1016\/j.vaccine.2016.01.040_bib0280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4419-8632-0_5","article-title":"Selection of diphtheria toxin active-site mutants in yeast. Rediscovery of glutamic acid-148 as a key residue","volume":"419","author":"Fu","year":"1997","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.040_bib0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"issue":"41","key":"10.1016\/j.vaccine.2016.01.040_bib0290","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.vaccine.2009.07.036","article-title":"Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages","volume":"27","author":"Broker","year":"2009","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2016.01.040_bib0295","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.vaccine.2008.01.022","article-title":"Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases","volume":"26","author":"Bardotti","year":"2008","journal-title":"Vaccine"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2016.01.040_bib0300","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0264-410X(00)00427-8","article-title":"Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection","volume":"19","author":"Ricci","year":"2001","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2016.01.040_bib0305","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2013.07.078","article-title":"Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines","volume":"31","author":"Tontini","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.040_bib0310","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CDLI.5.4.479-485.1998","article-title":"A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses","volume":"5","author":"Granoff","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.040_bib0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(86)90268-1","article-title":"Antibody avidity determination by ELISA using thiocyanate elution","volume":"86","author":"Pullen","year":"1986","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2016.01.040_bib0320","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.040_bib0325","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","article-title":"The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies","volume":"73","author":"Giuliani","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.040_bib0330","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1365-2958.2000.01980.x","article-title":"Escherichia coli translocase: the unravelling of a molecular machine","volume":"37","author":"Manting","year":"2000","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.040_bib0335","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/AEM.01804-06","article-title":"The presence of N-terminal secretion signal sequences leads to strong stimulation of the total expression levels of three tested medically important proteins during high-cell-density cultivations of Escherichia coli","volume":"73","author":"Sletta","year":"2007","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.040_bib0340","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.vaccine.2014.11.026","article-title":"Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation","volume":"33","author":"Pecetta","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.040_bib0345","first-page":"77","article-title":"Can animal models predict protection provided by meningococcal vaccines?","volume":"3","author":"Finney","year":"2006","journal-title":"Drug Discovery Today: Dis Models"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2016.01.040_bib0350","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0264-410X(00)00261-9","article-title":"Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines","volume":"19","author":"Ho","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.040_bib0355","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol: CVI"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.040_bib0360","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.040_bib0365","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/erv.12.137","article-title":"Preclinical evaluation of MenB vaccines: prerequisites for clinical development","volume":"12","author":"Sanders","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2016.01.040_bib0370","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum Vaccines Immunother"},{"issue":"18","key":"10.1016\/j.vaccine.2016.01.040_bib0375","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/anie.201006327","article-title":"A coordinated synthesis and conjugation strategy for the preparation of homogeneous glycoconjugate vaccine candidates","volume":"50","author":"Grayson","year":"2011","journal-title":"Angew Chem Int Ed"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.040_bib0380","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/ar200056q","article-title":"A \u201ctag-and-modify\u201d approach to site-selective protein modification","volume":"44","author":"Chalker","year":"2011","journal-title":"Acc Chem Res"},{"issue":"8","key":"10.1016\/j.vaccine.2016.01.040_bib0385","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1039\/c3sc50862e","article-title":"Synthetically defined glycoprotein vaccines: current status and future directions","volume":"4","author":"Adamo","year":"2013","journal-title":"Chem Sci"},{"key":"10.1016\/j.vaccine.2016.01.040_bib0390","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1039\/C4SC01361A","article-title":"Deciphering the structure\u2014immunogenicity relationship of anti-Candida glycoconjugate vaccines","volume":"5","author":"Adamo","year":"2014","journal-title":"Chem Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T23:41:05Z","timestamp":1654213265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16000840"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the non-toxic mutant of the diphtheria toxin K51E\/E148K as carrier protein for meningococcal vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}